AirSculpt Technologies Hits New 52-Week High of $11.44, Up 174%

AirSculpt Technologies, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 11.44 on October 24, 2025. This achievement marks a remarkable increase in the stock's performance, with a one-year gain of 174.46%, significantly outpacing the S&P 500's performance of 16.9% during the same period.
With a market capitalization of USD 387 million, AirSculpt operates in a competitive industry characterized by innovation and growth potential. Despite its recent stock performance, the company remains in a loss-making position, as indicated by its price-to-earnings ratio, which is not applicable. The firm has a debt-to-equity ratio of 0.63, suggesting a moderate level of leverage, while its return on equity stands at -11.92%. Additionally, the stock has a price-to-book ratio of 4.25, reflecting its valuation relative to its net assets.

As AirSculpt Technologies continues to navigate the dynamic landscape of the pharmaceuticals and biotechnology industry, its recent stock performance underscores its current market position and the trends influencing its growth.